Not investment advice.. Spectrascience is on the verge

New Post Public Reply Private Reply Replies (0) Message Board
joey68
Not investment advice..

Spectrascience is on the verge of sales.

From January 2015 Endoscopy Journal:

Quote:
Both accuracy of WavSTAT alone and the algorithm combining HRE with WavSTAT proved to be insufficient for the in vivo differentiation of small colorectal lesions, and do not fulfill American Society for Gastrointestinal Endoscopy performance thresholds for assessment of diminutive lesions. Future studies should assess whether combining WavSTAT with more advanced imaging techniques could result in a higher accuracy. Netherlands Trial Registry (NTR 3235).


This conclusion was based off of 2011 data which used the WavSTAT3; one version prior to the current WavSTAT4. Notice it says the WavSTAT did NOT meet ASGE standards.

Now read this:
Click link if you cant see image
http://i.imgur.com/72RqYlA.png

72RqYlA.png


The quote in the above image is directly referencing the first quote. The first quote clearly states from January 2015 (using 2011 data) that the WavSTAT was not proven to be sufficient for the in vivo differentiation of small colorectal lesions .

But notice it says Spectrascience put in "additional R&D" into the WavSTAT4, which enhanced the PREDICTIVE VALUE which EXCEEDS ASGE guidelines .

This is what Spectrascience needed in order to begin sales. The WavSTAT4 works. Plain and simple, it works!

SCIE has a product that works and the next step is to sell the darn thing. They didn’t spend the past several years improving the WavSTAT1, WavSTAT2, WavSTAT3, and WavSTAT4 in order to stuff it into some dusty old closet. They improved it in order to make it sellable and it IS!

Any and all naysayers can respond to this with blubbering posts, off topic comments, and out of context quotes, but once again, they still lack evidence which shows the WavSTAT4 (not the WavSTAT3) doesn’t work. BECAUSE IT WORKS! (Still waiting for ONE link from the previous 6 months which states the WavSTAT4 doesn't work)

Read the links, do the DD. Do your own DD. Make your own investment decisions. This isn't investment advice.

http://www.spectrascience.com/investors/pdf/S...5-2015.pdf
http://www.ncbi.nlm.nih.gov/pubmed/25264763

Note
And if you don't know who Dr. Helmut Neumann is, it may be good to do some DD as he is a very reputable leader in the field of endoscopy.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Globant Unleashes MuleSoft AI Pod for Faster Integration

Updated Category News Views 1

Unlocking the AI Puzzle: Webinar Speed Dials You ever swim through a mash-up of tech lingo that makes you feel like you're trudging through waist-high molasses? Well, Saddle up because that's exactly where Globant's new MuleSoft AI Pod is heading. Through Glob.AI, they're going all in on turning what used to take months into mere weeks—finally, right? In the business of...

Continue Reading
Nanochon Tests Innovative Knee Implant in Human Trial

Updated Category News Views 2

Mending Knees with New Tech: The Chondrograft™ Debut Picture this: Nanochon's Chondrograft™ just hit the ground running. They've got a bite out of the future by diving headfirst into their First-in-Human (FIH) clinical study. This ain't your grandma's knee replacement talk. This is about changing the game for those knee cartilages that let out a groan every time you...

Continue Reading
Honoring Dr. Drew's Impact on Blood Banking History

Updated Category News Views 0

Legacy of Dr. Charles R. Drew Comes Alive Here's one for the books: a legacy that's still saving lives 85 years after it began. Dr. Charles R. Drew, the mastermind behind blood banking, is getting his due respect with a documentary called Iconic Excellence. No fluff here—this film unveils how the man's breakthroughs during World War II laid down the bedrock of modern...

Continue Reading
Mohegan Sun's Star-Studded 30th Year Bash: Details Inside

Updated Category News Views 1

Mohegan Sun Hits the Big 3-0 with a Bang When a casino decides to throw a party, you already know they spare no expense. Mohegan Sun's hitting the big thirty this October, and they've got a lineup that screams celebration. This isn’t just about a glossy red carpet or celebrity sightings, folks. It’s about a milestone that reflects years of stellar entertainment,...

Continue Reading
Triskell Debuts in Gartner's 2026 Magic Quadrant

Updated Category News Views 1

Triskell Software Makes Its Mark Kicking off September 2026 with a bang, Triskell Software finds itself on the illustrious 2026 Gartner Magic Quadrant for Adaptive Project Management and Reporting (APMR). This marks the first time the Madrid-based company nabs a spot here, and it's a significant feather in their cap. Just think, out of the 11 vendors invited to this...

Continue Reading
Codoxo Snags 2026 Award for AI Payment Innovation

Updated Category News Views 3

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...

Continue Reading
Nonprofit Option Rises for Specialty Physicians

Updated Category News Views 0

Reimaging Choices for Specialty Physicians In the whirlwind of healthcare, specialty physicians often find themselves between a rock and a hard place. The traditional paths are either hug a major health system or auction off to private equity, each option chaining them to systems more interested in the balance sheet than in patient care. But now, a third door opens. One...

Continue Reading
TELUS Digital Shakes Up Dreamforce with Exclusive Session

Updated Category News Views 7

What's Cooking at Hotel Zetta? Ever see a company shake up an event like TELUS Digital is about to at Dreamforce 2026? Instead of the usual booth schmooze-fest at Moscone Center, these folks are camping at Hotel Zetta with a packed 'boutique' agenda. From September 15–16, they're rolling out serious insider sessions for the big brains in financial services, education,...

Continue Reading
Mitrade EU Enhances Investor Safety with New Insurance

Updated Category News Views 4

Mitrade's New Insurance: A Safety Net? Mitrade EU is amping up its game with some fresh insurance perks that catch the eye. They're slapping on some extra insolvency protection for clients trading under their CySEC license. Now that sounds like a financial shield anyone would want. Basically, they're adding another layer to the basic regulatory protections, and without...

Continue Reading
Royal Mint Ventures Into the Final Frontier with Star Trek Coins

Updated Category News Views 2

A Cosmic Coin Collection for the Ages The Royal Mint has stepped boldly into a realm where no coin has gone before—celebrating six decades of Star Trek with two new collectable 50p coins. For Star Trek fans who’ve followed the Enterprise to the furthest reaches of the galaxy, these coins aren’t just chump change—they’re keepsakes that capture a piece of sci-fi...

Continue Reading

Top 5 Most Recently Viewed Articles

Vooglam Unveils Unique Boho Chic Eyewear Collection Today

Updated Category News Views 146

Vooglam's Innovative Boho Chic Collection Vooglam is excited to present its latest offering, the Boho Chic Collection, a creative tribute to individuality and free spirit. This collection draws its inspiration from the lively energy of the 1970s and 1980s, merging the vibrant aesthetic of those decades with contemporary style. If you are in search of eyewear that speaks...

Continue Reading
Asure and PensionBee Forge Strategic Alliance for Retirement Solutions

Updated Category News Views 190

Asure Partners with PensionBee to Enhance Employee Benefits AUSTIN, Texas and NEW YORK – Asure Software (NASDAQ: ASUR), a prominent provider of cloud-based Human Capital Management (HCM) software, has entered into a strategic partnership with PensionBee, a digital-first retirement savings platform. This collaboration marks a significant step forward in providing small...

Continue Reading
Natural Remedies for Herpes Outbreaks Amid Market Growth

Updated Category News Views 375

Natural Remedies for Herpes Outbreaks In recent years, there has been an increasing interest in natural remedies to manage herpes outbreaks. As consumer awareness around health continues to evolve, the market for dietary supplements has expanded significantly, reaching a notable $1.23 billion. Amidst this backdrop, Herpafend has emerged as a key player, offering a unique...

Continue Reading
Alcoa's Strategic Shift Amid U.S. Aluminum Tariffs

Updated Category News Views 555

Alcoa's Response to Potential U.S. Tariffs Alcoa (NYSE: AA) is on the verge of a significant operational shift. The company’s CEO, William Oplinger, has indicated that if the United States decides to impose tariffs on Canadian imports, Alcoa could redirect its aluminum production from Australia to the U.S. This approach aims to adapt to new trade barriers while...

Continue Reading
Tachyus Partners with Anschutz for Enhanced Carbon Management

Updated Category News Views 164

Tachyus Partners with Anschutz Exploration Tachyus has announced an exciting collaboration with Anschutz Exploration to implement Aurion, its innovative platform designed for efficient greenhouse gas (GHG) emissions management. This contract marks a significant step for Anschutz, aiming to establish a comprehensive GHG baseline while effectively monitoring and forecasting...

Continue Reading